Tatjana Ivaskiene1*†Jonas Viskelis2†Paulina Streimikyte2†Milda Savickaitė1†Ali Mobasheri1,3,4,5†
Greta Kaspute1†- 1State Research Institute Centre for Innovative Medicine, Vilnius, Lithuania
- 2Lithuanian Research Centre for Agriculture and Forestry, Institute of Horticulture, Babtai, Lithuania
- 3Research Unit of Health Sciences and Technology, Faculty of Medicine, University of Oulu, Oulu, Finland
- 4Department of Joint Surgery, First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China
- 5Faculty of Medicine, Université de Liège, Liège, Belgium
Collagen, the most abundant structural protein in the human body, plays a key role in skin integrity, tissue repair, and extracellular matrix organization. With increasing consumer and clinical interest, collagen supplementation has expanded rapidly, yet scientific evidence supporting its efficacy in anti-aging and regenerative applications remains inconsistent. This review critically evaluates current evidence on oral collagen supplementation, integrating insights from over 60 clinical studies assessing its effects on skin aging, musculoskeletal health, and hair disorders. Emerging data suggest that hydrolyzed collagen peptides may improve skin elasticity, joint function, and recovery after exercise, particularly when co-supplemented with vitamin C, silica, or resveratrol. Beyond supplementation, recent advances in biosensing and material science have enabled novel approaches to collagen detection and targeted delivery. Electrochemical, optical, and molecularly imprinted polymer (MIP)-based biosensors facilitate real-time monitoring of collagen biomarkers such as CTX-I, MMPs, and hydroxyproline, supporting precision assessment of collagen metabolism. In parallel, collagen-based hydrogels, nanoparticles, and electroresponsive scaffolds have shown promise as biocompatible carriers for controlled drug release and regenerative therapy. Collectively, these developments outline a translational framework connecting collagen supplementation, detection, and delivery. Continued integration of biosensing and smart material technologies may enhance clinical monitoring and therapeutic efficacy, advancing collagen-based interventions toward precision dermatology and regenerative medicine.
1 Introduction
Collagen is the most abundant structural protein in the human body, comprising approximately 30% of total protein content (1). As a key component of connective tissues—including skin, cartilage, tendons, and bone—collagen plays a fundamental role in maintaining tissue architecture, mechanical strength, and cellular signaling. In the skin, particularly the dermis, collagen types I and III provide tensile strength and elasticity, both of which decline significantly with age due to intrinsic and extrinsic factors such as ultraviolet (UV) exposure, hormonal changes, and oxidative stress (2).
Growing interest in anti-aging and skin health has fueled the development of collagen-based interventions, particularly oral supplements and topical formulations containing hydrolyzed collagen peptides (CPs) (3). Preliminary studies suggest that CPs, especially those derived from bovine or marine sources, may improve skin hydration, elasticity, and dermal density (4). These effects are hypothesized to arise from enhanced fibroblast activity, increased synthesis of extracellular matrix proteins such as elastin, and reduced expression of matrix metalloproteinases (MMPs) that degrade native collagen. However, while in vitro and small-scale clinical studies offer promising results, robust evidence from large randomized controlled trials (RCTs) remains limited (5).
The rapid expansion of the collagen supplement market—valued at nearly USD 2 billion in 2021—has outpaced scientific consensus, with many products marketed as broad-spectrum solutions for aging skin, hair loss, and joint health (6). This discrepancy underscores the need for objective biomarkers to assess collagen metabolism and treatment efficacy (7). Emerging technologies, such as electrochemical sensors and molecularly imprinted polymers (MIP) (8), offer potential for non-invasive, sensitive, and selective detection of collagen or its metabolites in biological fluids (9–11). These tools could enhance both clinical research and personalized dermatologic care by enabling real-time monitoring of collagen-related interventions (12, 13).
This review aims to fill that gap by providing a comprehensive, interdisciplinary synthesis of current clinical evidence, detection technologies, and biomaterial innovations related to collagen. It highlights how biosensors and electroresponsive delivery systems can enhance monitoring, efficacy, and safety of collagen-based interventions. The target audience includes clinicians, biomedical researchers, and biomaterials scientists seeking to understand how advances in sensing and delivery can translate nutritional supplementation into clinically meaningful outcomes in dermatology, regenerative medicine, and anti-aging therapeutics. In addition, despite the growing number of publications on collagen supplementation and biomaterial applications, the field remains fragmented across nutrition, dermatology, and materials science. Previous reviews have primarily focused on either the biochemical properties of collagen or its cosmetic and orthopedic applications, without integrating emerging evidence from biosensing and advanced delivery systems. Consequently, there is a lack of a unified framework linking collagen supplementation, real-time detection technologies, and drug delivery platforms, which together could enable personalized and feedback-controlled collagen therapies.
2 Methods
A comprehensive literature search was conducted using PubMed and ScienceDirect to identify studies investigating the effects of collagen supplements on health and cosmetic outcomes as well as electrochemical studies related to collagen (Figure 1).
Figure 1. Schematic representation of the search strategy employed in this review article.
2.1 Search strategy
The search was performed for publications from January 2020 and October 2025 to ensure inclusion of the most recent data. The following terms were used for this search:
1. Pubmed: ((collagen) AND (supplement)) AND (health OR cosmetic)
2. ScienceDirect: (collagen AND electrochemistry) OR (collagen AND drug delivery)
Filters were applied to include books and documents, case reports, clinical studies, and clinical trials (Phases I-IV), and exclude reviews and animal studies.
Studies were selected according to predefined criteria to ensure relevance and methodological rigor (Table 1).
Table 1. Inclusion and exclusion criteria.
2.2 Screening and methodological assessment
Following the initial search, a total of 460 articles were identified, with 89 studies being deemed relevant for inclusion in the review. Of the eligible studies, 32 were excluded after further review due to methodological concerns, such as insufficient sample size or lack of control group, incomplete outcome reporting, non-standardized collagen formulations or dosages, or lack of statistical analysis. In the final, this process resulted in leaving 57 studies that met the inclusion criteria for analysis.
In addition, to compile relevant data for this review, a comprehensive search was conducted using ScienceDirect, focusing on peer-reviewed research articles. The search terms were “collagen,” “electrochemistry,” and “drug delivery.” A total of 67 articles were identified, of which 9 met the inclusion criteria following relevance screening. These studies focused on the role of collagen in biosensing and drug delivery systems, emphasizing electrochemical detection and monitoring strategies. The summarized schematic representation of the search results is presented in Figure 1.
Data from all included studies were extracted manually, summarizing author, year, study design, sample size, collagen source and dosage, duration and main findings. The results were synthesized narratively due to heterogeneity in study designs and outcomes.
3 Clinical evidence and biological effects of collagen supplementation
Collagen supplementation has emerged as a promising intervention in dermatologic and musculoskeletal health, supported by a growing body of clinical and molecular evidence. Recent RCTs demonstrate that bioactive CPs, particularly from marine and bovine origins, exert targeted effects on skin elasticity, hydration, wrinkle reduction, and joint function.
3.1 Molecular mechanisms of collagen action
Orally ingested hydrolyzed collagen is absorbed as di- and tripeptides (e.g., Pro-Hyp, Gly-Pro-Hyp) that act as signaling molecules to activate dermal fibroblasts, upregulate hyaluronic acid synthesis, and stimulate expression of collagen types I and III (14–17). These peptides also inhibit MMP-1 and MMP-3, reducing collagen degradation, particularly under UV or oxidative stress conditions (5, 14). In vitro studies further confirm that collagen peptides enhance elastin production and fibroblast proliferation, effects potentiated by co-supplementation with antioxidants, silicon, or vitamins D and E, (15–20) all of which support enzymatic hydroxylation of proline residues necessary for collagen stabilization. Silicon, in nanoparticle form, has been shown to directly upregulate collagen gene expression and enhance skin barrier function in human trials (21).
Collagen turnover in the skin is intricately regulated by mechanical tension, cytokine signaling, and cellular senescence (22). Mechanical forces exerted by dermal fibroblasts are essential for maintaining extracellular matrix (ECM) integrity. In young skin, fibroblasts adhere to a robust collagen network, generating tension that promotes collagen synthesis and suppresses MMP activity (23). However, with aging, collagen fibers become fragmented, leading to reduced mechanical tension, fibroblast collapse, and diminished collagen production. This loss of tension also downregulates transforming growth factor-beta (TGF-β) signaling by decreasing TGF-β type II receptor expression, further impairing ECM maintenance (24, 25). Reduced fibroblast contractility and chronic inflammation (inflammaging) contribute to ECM fragmentation and impaired repair (26). Targeting these mechanisms through functional foods, microbiome-derived bioactives [e.g., L. plantarum (27)], and polyphenols such as resveratrol and fermented pomegranate extract represents a new frontier in dermatologic anti-aging strategies (28, 29).
3.2 Clincal evidence and personalised effects of collagen
The reviewed studies collectively demonstrate encouraging evidence for collagen supplementation across dermatologic and systemic outcomes. However, methodological diversity, inconsistent dosing regimens, and variable outcome measures complicate direct comparisons. A critical appraisal of recent RCTs reveals both convergence in certain findings and notable gaps in standardization and mechanistic understanding. For example:
1. Skin hydration and elasticity (within 4–12 weeks) with 2.5–10 g/day of marine or porcine collagen peptides (30–32).
2. Wrinkle depth reduction, especially periorbital lines, in postmenopausal women (31).
3. Hair thickness and reduced shedding, when collagen was combined with micronutrients and antioxidants (33).
4. Nail brittleness, where improvements were observed after 6 months of supplementation (34).
A broader spectrum of clinical trials evaluating collagen supplementation across dermatologic and systemic indications is summarized in Table 2.
Table 2. Clinical trials on collagen supplementation.
Beyond dermatology, collagen supplementation also improved musculoskeletal parameters, including reduced joint pain in osteoarthritis (35–37) and enhanced tendon resilience in athletes (38). Notably, Shilajit supplementation has recently emerged as a novel enhancer of type I collagen synthesis, with a significant rise in serum pro-c1α1 levels after 8 weeks in trained men (39). The clinical effects of collagen appear to be dose- and population-dependent. While 2.5–5 g/day may suffice for skin-related outcomes, higher doses (10–20 g/day) are more effective in muscle recovery, joint health, and Bone mineral density (BMD) enhancement (40–42). Athletes (43, 44) and older adults (32, 45) often exhibit greater responsiveness, likely due to baseline deficits in collagen turnover or repair mechanisms. Despite the promising outcomes, heterogeneity in peptide source, formulation, and outcome measures limits direct comparisons across studies. Long-term trials with standardized endpoints and mechanistic biomarkers (e.g., pro-collagen type I (Pro-C1), C-terminal telopeptide (CTX)) are warranted to validate durability and systemic effects.
3.3 Methodological comparison and evidence quality
A comparative evaluation of the clinical trials summarized in Table 2 highlights significant heterogeneity in study design, sample size, dosage, and outcome measures, which collectively influence the strength of evidence. Most studies between 2020 and 2025 were RCTs, with approximately two-thirds adopting double-blind, placebo-controlled designs, while the remainder were open-label or single-arm interventions. This methodological variation affects the internal validity and reproducibility of findings.
Across the 28 clinical trials summarized in Table 2, the average sample size was approximately 93 ± 54 participants (range: 8–300), with most studies enrolling between 60 and 120 subjects. The mean intervention duration was 11.6 weeks, reflecting the predominance of 8- to 12-week RCTs, though a few extended to 18- or 24-week follow-ups. The average daily collagen dosage was 8.4 ± 5.6 g, with dermatologic studies clustering around 2.5–10 g/day and musculoskeletal or metabolic studies using 10–20 g/day. In total, 82% of trials reported at least one significant positive outcome, most commonly improvements in skin hydration and elasticity (44%), joint pain reduction or mobility (29%), and muscle recovery or composition (18%). Only 7% of studies found no measurable difference versus placebo. Collectively, these values underscore a dose- and duration-dependent trend, with higher daily intake and longer interventions yielding more robust and systemic benefits.
Outcome assessment methods varied across research domains. Skin studies employed instrumental techniques (corneometer, cutometer, ultrasound) and standardized photographic grading, while musculoskeletal studies used patient-reported pain scales, strength tests, and biochemical markers such as PINP and CTX. Analytical diversity—ELISA vs. LC–MS biomarker quantification—introduces inter-study variability. Few trials reported compliance monitoring, dietary control, or long-term follow-up beyond 6 months, limiting conclusions about durability and safety.
Overall, while most RCTs demonstrated positive and statistically significant effects, evidence quality is constrained by short intervention periods, lack of standardized collagen formulations, and small sample sizes in specific subpopulations. Future research should emphasize multi-center, longer-term, double-blind RCTs with unified dosage ranges, validated outcome measures, and mechanistic biomarker endpoints to enhance comparability and clinical relevance.
4 Collagen supplementation
Collagen supplements vary by source and formulation, each with distinct clinical applications.
4.1 Types of collagen supplements
Animal-derived CPs, including marine, bovine, and porcine sources, dominate current use due to their favorable bioavailability and documented efficacy in dermatologic and musculoskeletal conditions. Synthetic analogs and human recombinant collagen are also being explored for regenerative medicine and wound healing, often in conjunction with nanomaterials that mimic native collagen structure and demonstrate hemostatic potential (46) (Table 3).
Table 3. Comparison of collagen supplementation types.
An increasing number in clinical research highlights the benefits of CPs. For example, a 12-week randomized trial showed that a supplement containing fish CPs, taurine, cysteine, methionine, iron, and selenium significantly improved hair growth outcomes in participants with alopecia, especially when combined with standard pharmacotherapy (33). Similarly, a 90-day intervention with fish cartilage CPs improved wrinkle appearance and collagen morphology, confirmed by confocal microscopy (47).
In joint health, CPs type II (HC-II) supplementation has been shown to reduce pain and improve musculoskeletal function. A study comparing hydrolyzed collagen type II (HC-II) and an essence of chicken-CP-II blend (EC-HC-II) found significant improvements in grip strength and fat-free mass, alongside reduced joint pain (35). The JUMPFOOD study, currently ongoing (NCT05407194), examines the synergistic effects of CP and vitamin C with exercise therapy in athletes with patellar tendinopathy (48). Moreover, a multi-collagen (types I, II, III) supplement improved pain, balance, and walking ability in patients with osteoarthritis after 8 weeks (35).
4.2 Hydrolysed collagen supplements
Native collagen is a large, triple-helical protein that requires enzymatic breakdown for absorption, limiting its bioavailability (49). In contrast, CPs is processed into low molecular weight peptides (3–6 kDa) (50), allowing for more efficient gastrointestinal absorption and systemic distribution (51, 52). Research has demonstrated that CPs, when ingested, are absorbed in the small intestine and can enter the bloodstream as bioactive oligopeptides, which may then exert beneficial effects on collagen metabolism (53, 54). This absorption mechanism highlights the potential for CPs from animal sources to be utilized effectively in dietary supplements, enhancing collagen levels in the body. This inefficiency can hinder the potential therapeutic effects of natural collagen, particularly in conditions like osteoarthritis and skin aging, where increased collagen synthesis is desired (55).
CPs significantly elevate plasma levels of amino acids like proline and hydroxyproline, which are essential for collagen synthesis (56). These peptides stimulate fibroblast and chondrocyte activity (55, 57), enhance hyaluronic acid production, and upregulate collagen type II synthesis (57). This improved efficacy positions CPs as the preferred form for therapeutic use in dermatology and joint health.
4.3 Plant-based claims of collagen boosters: evidence and limitations
In recent years, there has been a growing trend toward vegan and plant-based nutrition, a movement that has also extended into the collagen supplement market. While traditional collagen supplements are animal-derived, plant-based alternatives are increasingly marketed as “collagen boosters” to appeal to vegan consumers (58, 59). However, the scientific evidence for collagen supplementation itself remains mixed. While several studies report improvements in skin elasticity and joint function with collagen supplementation (60), these findings are not universally consistent. Many trials have small sample sizes, short durations, or industry sponsorship, which raises concerns about generalizability and potential bias. Furthermore, some reported benefits may be attributable to overall protein intake rather than collagen-specific effects. Plant-based supplements face even greater challenges, as plants do not contain collagen. Claims that bamboo extracts, polysaccharides, or phytoestrogens stimulate fibroblast collagen production are largely unsupported (61–63), with most evidence limited to in vitro studies that lack clinical translation. Likewise, antioxidants such as green tea catechins, lycopene, and other polyphenols may reduce oxidative stress and protect existing collagen from degradation (64, 65), but there is no convincing evidence that they promote collagen synthesis or meaningfully improve skin or joint health. These limitations underscore the need for more rigorous evaluation, as the current literature tends to overstate preliminary findings. Emerging technologies may help bridge this gap: biosensors capable of real-time monitoring of collagen-related biomarkers (e.g., hydroxyproline, MMP activity) could improve the objectivity of efficacy assessments, while advanced drug delivery systems may enhance the bioavailability of collagen peptides. Together, these approaches could provide the robust evidence required to distinguish genuine biological effects from marketing exaggeration.
5 Electrochemical sensors and collagen delivery systems
Collagen has emerged as a versatile biopolymer carrier for drug delivery, capitalizing on its biocompatibility, biodegradability, and intrinsic tissue affinity. Its native triple-helical structure, enriched with amino acids such as glycine, proline, and hydroxyproline, provides abundant functional groups (–NH₂, –COOH, –OH) for chemical modification, cross-linking, or drug conjugation, thereby enabling both controlled release and targeted delivery. Depending on the formulation strategy, collagen can function as a hydrogel matrix, nanocarrier, or stimuli-responsive scaffold, allowing sustained and localized release of therapeutic agents.
Recent advancements have also integrated collagen with electrochemical biosensors and nanostructured delivery systems (e.g., nanoparticles, hydrogels, microneedle arrays) to achieve precise, real-time monitoring of drug diffusion and targeted release of collagen peptides for optimized therapeutic outcomes. These systems combine collagen’s biological compatibility with the sensitivity and selectivity of sensor platforms, offering a synergistic approach to personalized medicine and dermatologic therapy.
5.1 Collagen sensing mechanisms
Electrochemical sensors were chosen for these applications due to their unique advantages over traditional analytical techniques such as ELISA, LC–MS, or spectroscopy. These sensors offer high sensitivity and selectivity, rapid response times, and the ability to perform real-time, in situ measurements with minimal sample preparation (8, 66). Such capabilities are particularly valuable in monitoring dynamic processes, such as the controlled release of collagen peptides from delivery matrices, where temporal resolution is critical. Additionally, electrochemical sensors are cost-effective, portable, and amenable to miniaturization, allowing integration with wearable or implantable delivery systems (8). This combination enables continuous monitoring of collagen peptide levels or other biomarkers, which is difficult to achieve with conventional endpoint assays.
Electrochemical collagen sensors rely on the specific recognition of collagen or collagen-derived peptides, followed by conversion of this biochemical interaction into an electrical signal. Common recognition strategies include enzyme-assisted cleavage, antibody or aptamer binding, and molecular imprinting (67, 68). For example, collagenase-sensitive electrodes detect changes in redox-active species upon peptide cleavage (69), while immunosensors use immobilized anti-collagen antibodies to selectively capture collagen molecules, generating measurable changes in current or impedance (70).
Key performance parameters in sensor studies include the limit of detection (LOD), limit of quantification (LOQ), linear range, and selectivity/interference studies (71). These are often determined using spiked biological samples such as serum, plasma, or tissue extracts to mimic real-world applications. For instance, the MIP electrochemical biosensor for serum CTx-I used interdigital capacitive electrodes combined with electrochemical impedance spectroscopy. It exhibited a linear range of 0.1–2.5 ng/mL, a LOD of 0.09 ng/mL, and was validated on sheep serum samples with good correlation to ELISA (12).
Wearable collagen sensors represent a significant advancement, integrating biocompatible collagen matrices with flexible substrates to allow real-time monitoring of collagen dynamics in sweat or interstitial fluid. These systems combine collagen’s natural affinity for extracellular matrix components with sensitive electrochemical transducers, enabling localized and continuous detection for dermatologic and regenerative medicine applications (9, 72, 73).
Overall, incorporating detailed sensing mechanisms and reporting analytical parameters such as LOD, LOQ, linear range, and real sample validation strengthens the understanding of collagen sensor performance and their translational potential in both clinical and consumer applications.
5.2 Biosensing platforms for collagen and related biomarkers
In particular, electrochemical sensors based on MIP have shown high promise for detecting and delivering collagen-related biomolecules. MIP are synthetic receptors that replicate the binding sites of target molecules. Electrochemical sensors based on MIP are typically constructed through non-covalent interactions such as hydrogen bonding, electrostatic attraction, and hydrophobic forces between the template and monomers (8, 74). Collagen, being amphiphilic, provides both hydrophilic (–OH, –COOH, –NH₂) and hydrophobic (–CH₂–, –CH₃) groups that can participate in these interactions, enabling the formation of stable and selective imprinted cavities domains (75).
Although electrochemical sensors based on MIP have shown considerable promise for detecting collagen-related biomarkers, most current applications focus on indirect targets such as the CTX-I (12), MMP-1, MMP-8 (76), or hydroxyproline—key indicators of collagen degradation and tissue remodeling (77). For instance, MIP-based impedance sensors have been developed for CTX-I quantification in bone turnover monitoring (12), and graphene oxide–MIP interfaces have been used to detect MMP-8 activity in periodontal disease (76). However, few MIP platforms directly recognize collagen peptides or the intact collagen molecule, largely due to the polymerization challenges posed by its large size, conformational complexity, and limited solubility. Therefore, there remains a critical need to design next-generation MIP sensors capable of selectively imprinting collagen fragments or characteristic peptide motifs, which would enable direct, real-time assessment of collagen supplementation, metabolism, and therapeutic response in biomedical and cosmetic contexts.
Consequently, collagen-based MIP can serve dual purposes: (1) as recognition elements in biosensors for detecting biomarkers or drug concentrations, and (2) as functional components of delivery systems, enabling feedback-controlled release in response to physiological cues such as pH, temperature, or enzymatic activity. This convergence of biopolymer chemistry, nanotechnology, and electrochemical sensing represents a key frontier in next-generation collagen therapeutics, particularly for skin regeneration, anti-aging formulations, and musculoskeletal repair.
Beyond electrochemical transduction, optical and piezoelectric platforms have also been applied to study collagen or its degradation products.
For example, surface plasmon resonance (SPR) biosensors allow label-free detection of MMP activity and collagen–ligand interactions (76, 78), while fluorescence-based assays using collagen-binding peptides (CBPs) enable visualization of matrix remodeling (79). Quartz crystal microbalance (QCM) sensors have also been used to monitor collagen film deposition and cross-linking kinetics (80).
5.3 Collagen-based delivery systems
Whole collagen molecules are difficult to use as biological drugs due to their insolubility, but collagen fragments of lower molecular weight, resulting from enzymatic degradation, are more suitable for drug development and have gained attention in pharmacological research. These collagen-derived fragments, known as matrikines or matricryptins, exhibit diverse biological activities, with some proving beneficial as potential therapeutic agents, while others may have harmful effects on health (46). Scientists proposed a simple mathematical model to estimate cartilage damage, considering factors such as age, obesity, gender, and overloading, while accounting for the cartilage’s self-repair capacity. The model assumes homogeneous distribution of cartilage components, including collagens, proteoglycans, and glycoproteins, and uses Python’s Numpy library for modeling and predictions. The results indicate that cartilage damage increases by 6.5% for each unit increase in BMI above 27, with critical damage occurring between the ages of 44 and 64, which aligns with clinical data (81).
Despite the ability to predict cartilage damage using mathematical models, electrochemical methods and sensors offer a real-time monitoring of collagen distribution and structural changes within the tissue. For example, an electrically active composite material made from a biocompatible hydrogel, gelatin methacryloyl (GelMA), and a conducting polymer, poly (3,4-ethylenedioxythiophene), is a conducting polymer hydrogel for controlled protein delivery. The short-term release of a model protein was controlled over 4 h with electrical stimuli, and extended-release studies over 21 days demonstrated a bimodal release profile influenced by GelMA degradation and electrical stimulation. This electroactive, cytocompatible material is ideal for tissue engineering applications that require targeted, spatio-temporal delivery of therapeutic proteins (82).
Peripheral nerve repair faces challenges due to the limited regenerative capacity of nerves and complications with autografts. Axons and myelin sheaths are encased by the endoneurium, which contains aligned collagen fibers, while the perineurium, composed of flattened fibroblasts and collagen, bundles the axons into fascicles (83). The fibrocollagenous epineurium surrounds the fascicles and vasculature (arteries and veins), holding them together to form the nerve trunk. Electrical stimulation has shown potential to enhance nerve regeneration by modulating the bioelectrical environment and promoting a reparative immune response. Electrically conductive polymer - based biomaterials offer advantages for nerve repair, combining flexibility, ionic-electronic conductivity, biocompatibility, and ease of fabrication (83).
Electrochemical therapy has also been explored to modulate dermal collagen architecture for scar treatment. Pham et al. described the use of electrochemical therapy creates focal pH gradients in skin, altering dermal collagen for scar treatment. By applying an electrical potential through platinum electrodes in porcine skin, the researchers observed biochemical and structural changes, including collagen denaturation, as confirmed by histology and imaging techniques (84). Another study investigated the use of short-duration topical co-iontophoresis to deliver cationic buflomedil hydrochloride (BUF) and anionic dexamethasone phosphate (DEX-P) to the oral mucosa in a novel concentric experimental setup. The iontophoresis procedure applied a constant current of 3.0 mA for 5, 10, and 20 min, resulting in a significant increase in drug delivery—BUF increased by nearly 6.5-fold and DEX-P by over 5-fold compared to passive controls. Quantification of drug migration revealed substantial lateral ion migration, with higher drug delivery observed in the cathodal and inter-electrode areas. The results suggest that short-duration co-iontophoresis can effectively and safely enhance local bioavailability, offering a promising and patient-friendly treatment for oral diseases like oral submucous fibrosis related to excessive collagen production (85).
5.4 From peptide self-assembly to functional biorecognition elements
The development of collagen mimetic peptides (CMPs) has garnered significant interest for their potential applications in tissue engineering, regenerative medicine, and biomaterials. In recent years, the self-assembly of small CMPs into large-scale collagen-like structures has been widely explored, offering new strategies for the creation of innovative biomaterials (86).
A polypyrrole (PPy)-based bipolar electrostimulation (BPES) system was applied for living cells. By utilizing PPy films doped with dextran sulfate and collagen (PPy-DS/collagen), the system demonstrated reversible and recoverable bipolar electrochemical activity under low DC voltage (<5.5 V). The BPES prototype, which uses these materials as bipolar electrodes, was successfully applied to rat pheochromocytoma cells, showing enhanced cell proliferation and differentiation (87).
The use of metal–organic frameworks, specifically collagen encapsulated strontium ranelate@PCN-224 enhanced the osseointegration of zirconium alloy implants by loading osteogenic drugs such as strontium ranelate (SR). The synthesized PCN-224, with a large surface area and specific pore structure, successfully adsorbed SR without altering its crystal structure, exhibiting a maximum adsorption capacity of 112.67 ± 2.14 mg g − 1. In vitro experiments demonstrated that the SR-loaded PCN-224 coating, when applied to zirconium alloy, promoted osteoblast proliferation and differentiation, offering a promising strategy to improve bone-implant integration (88). Another study explored the incorporation of wool, choline dihydrogen phosphate ([Ch][DHP]), or choline serinate ([Ch][Ser]) ionic liquids (ILs) into native collagen formulations to create films via compression molding. Scanning electron microscopy confirmed the good dispersion of additives without agglomeration, while differential scanning calorimetry and infrared spectroscopy demonstrated that the collagen fibrillary structure remained intact. X-ray diffraction patterns supported these findings, showing that the addition of wool or ILs enhanced tensile strength, electrical conductivity, and antistatic behavior. The films also exhibited a high dielectric constant, primarily from mobile charge contributions, highlighting the potential of these collagen-based materials for a wide range of sustainable applications (89).
Scientists synthesized the CMP (Pro-Hyp-Gly) 10, referred to as POG10, and investigated its interactions with varying concentrations of choline chloride (ChCl) using a variety of biophysical techniques, including circular dichroism, UV–vis spectroscopy and other. For the first time, scientists demonstrated how ChCl can be used to modulate the stability and aggregation of CMP triple helices, shedding light on the factors that influence the stability of these structures (86).
5.5 Collagen-based hydrogels, nanoparticles and liposomal systems
Collagen-based hydrogels and nanoparticles have gained substantial attention as next-generation drug delivery platforms, owing to their tunable mechanical strength, high water content, and intrinsic bioactivity. Collagen’s natural cell-adhesive motifs and enzymatic degradability enable it to serve as a responsive and biocompatible matrix for sustained and localized release of therapeutic agents. These systems can be engineered to respond to biological or external stimuli—such as enzymatic degradation, pH, temperature, or electrical input—allowing for precise spatiotemporal control of drug release (90, 91). Their key advantages include biocompatibility, minimal immunogenicity, and versatility in integrating growth factors, small molecules, or peptides for tissue regeneration and wound healing applications (92).
Several examples already discussed illustrate the diversity of collagen-based hydrogel and nanoparticle systems. For instance, electrically conductive GelMA–PEDOT hydrogels enabled electroresponsive protein release over a 21-day period (82), while collagen-encapsulated metal–organic frameworks such as SrR@PCN-224 enhanced osteoblast differentiation and osseointegration on zirconium alloy implants S (88). These studies highlight the capacity of collagen matrices to function as bioactive carriers capable of synergizing with nanostructured or electroactive components to improve delivery precision and therapeutic outcomes.
Beyond laboratory research, collagen-based nanostructures have also entered translational and commercial stages. For example, Liposovit®-Collagen Direct, incorporates liposomal hydrolyzed fish collagen type I (< 300 nm particle size) to improve bioavailability and dermal absorption, representing one of the first marketed liposomal collagen formulations for skin and joint health. Similarly, injectable collagen–polyethylene glycol hydrogels loaded with stem cell factor have been developed for diabetic wound healing, demonstrating accelerated re-epithelialization and improved vascularization (93). Nanoparticulate mineralized collagen-glycosaminoglycan scaffolds have further shown bone-regeneration potential without exogenous growth factors in vivo (94). Commercial collagen wound dressings, such as absorbable collagen matrices, have already gained FDA 510(k) clearance, confirming their biocompatibility and clinical applicability (95).
Despite these achievements, several limitations persist. Collagen hydrogels often suffer from rapid enzymatic degradation and weak mechanical integrity under physiological loading conditions, while nanoparticle formulations may face challenges related to reproducibility, limited drug loading capacity, and undesirable burst release effects. The integration of conductive polymers or inorganic nanoparticles, though beneficial for electrical responsiveness and bioactivity, can raise cytotoxicity concerns if residual monomers or metal ions leach from the matrix. Achieving a stable balance between biodegradability, biofunctionality, and electrochemical responsiveness remains a central materials-engineering challenge (82).
The increasing scientific interest in collagen-based nanotechnology and hydrogel systems reflects both their practical advantages and their appeal for translational medicine. They are relatively simple to synthesize, allow control over drug distribution, and can be monitored for their movement and release dynamics within biological environments. Moreover, the integration of nanotechnology enhances marketing potential—patients and consumers are drawn to innovative formulations that promise faster and more visible effects. Liposomes, in particular, are a widely adopted vehicle in pharmaceutical and cosmetic industries because of their established safety profile and enhanced delivery efficiency. However, while many collagen-containing liposomal and hydrogel formulations are marketed for cosmetic or nutraceutical purposes, only a few have undergone rigorous clinical testing to confirm long-term efficacy or systemic safety.
This disparity underscores a critical translational gap: although numerous studies report promising in vitro and in vivo performance of collagen-based nano-hydrogel systems, there is still a lack of regulatory-approved, sensor-integrated, or collagen-fragment-specific delivery systems. Bridging this gap requires standardized protocols for evaluating stability, release kinetics, and biocompatibility, as well as integrated analytical methods—such as electrochemical or optical biosensors—to monitor collagen degradation and therapeutic response in real time. Ultimately, advancing these hybrid materials from laboratory prototypes to clinically approved therapies will depend on the successful reconciliation of their physicochemical complexity with practical safety, manufacturability, and regulatory compliance.
6 Conclusion
Collagen, the most abundant structural protein in the human body, underpins the integrity and function of skin, cartilage, and bone. Its biosynthesis is a complex, multistep process initiated in the endoplasmic reticulum and catalyzed by key enzymes such as prolyl hydroxylases and peptidyl-prolyl cis-trans isomerases. Dysregulation or mutation in these pathways can impair tissue homeostasis, repair, and extracellular matrix remodeling.
Contemporary collagen research increasingly bridges the domains of nutritional supplementation, biosensing, and drug delivery, forming an integrated framework that supports precision medicine and regenerative healthcare. Collagen supplementation provides essential substrates—hydrolyzed peptides and amino acids—that stimulate endogenous collagen synthesis and promote tissue repair. However, interindividual variability in absorption, metabolism, and physiological response leads to heterogeneous clinical outcomes, underscoring the need for real-time monitoring tools capable of assessing collagen turnover, degradation, and remodeling in vivo.
Emerging electrochemical and optical biosensing platforms—including molecularly imprinted polymer (MIP)-based sensors, surface plasmon resonance systems, and fluorescence assays utilizing collagen-binding peptides (CBPs)—enable dynamic, label-free detection of key collagen-related biomarkers such as CTX-I, MMPs, and hydroxyproline. These sensing tools can provide quantitative feedback on collagen metabolism, facilitating personalized supplementation strategies that optimize dose, source, and treatment duration according to patient-specific biomarker profiles.
Concurrently, collagen-based hydrogels, nanoparticles, and electroresponsive scaffolds function as smart delivery systems capable of controlled, stimuli-responsive release of therapeutic agents—including peptides, growth factors, and antioxidants. Integration of biosensors within these delivery matrices could establish closed-loop feedback systems, wherein biomarker fluctuations (e.g., collagen degradation or peptide concentration) directly trigger or modulate therapeutic release in real time. Such convergence of sensing and delivery may significantly enhance treatment precision and reduce systemic side effects.
Moving beyond population-level interventions, personalized collagen therapeutics will rely on integrative strategies that combine mathematical modeling, biosensing, and molecular diagnostics to monitor and guide therapy. Moreover, collagen mimetic peptides (CMPs) provide novel avenues for regenerative medicine, offering bioinspired building blocks that mimic native collagen’s structural and functional properties.
In summary, advancing collagen research requires a systems-level approach that connects biochemical mechanisms, sensor-driven diagnostics, and material-based delivery technologies. This conceptual integration will form the foundation for the next generation of data-informed, adaptive collagen therapies in dermatology, orthopedics, and regenerative healthcare.
Author contributions
TI: Data curation, Funding acquisition, Writing – original draft. JV: Formal analysis, Investigation, Writing – original draft. PS: Conceptualization, Investigation, Methodology, Writing – original draft. MS: Formal analysis, Project administration, Software, Validation, Writing – review & editing. AM: Funding acquisition, Methodology, Resources, Supervision, Writing – review & editing. GK: Conceptualization, Data curation, Project administration, Resources, Supervision, Visualization, Writing – original draft, Writing – review & editing.
Funding
The author(s) declare that no financial support was received for the research and/or publication of this article.
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Generative AI statement
The authors declare that no Gen AI was used in the creation of this manuscript.
Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
References
1. Tarnutzer, K, Sankar, DS, Dengjel, J, and Ewald, CY. Collagen constitutes about 12% in females and 17% in males of the total protein in mice. Sci Rep. (2023) 13:4490. doi: 10.1038/s41598-023-31566-z
2. Deshmukh, SN, Dive, AM, Moharil, R, and Munde, P. Enigmatic insight into collagen. J Oral Maxillofacial Pathol. (2016) 20:276–83. doi: 10.4103/0973-029X.185932
3. Jadach, B, Mielcarek, Z, and Osmałek, T. Use of collagen in cosmetic products. Curr Issues Mol Biol. (2024) 46:2043–70. doi: 10.3390/cimb46030132
4. Pappelbaum, KI, Virgilio, N, Epping, L, van der Steen, B, Jimenez, F, Funk, W, et al. Revealing novel insights on how oral supplementation with collagen peptides may prevent hair loss: lessons from the human hair follicle organ culture. J Funct Foods. (2024) 116:106124. doi: 10.1016/j.jff.2024.106124
5. Edgar, S, Hopley, B, Genovese, L, Sibilla, S, Laight, D, and Shute, J. Effects of collagen-derived bioactive peptides and natural antioxidant compounds on proliferation and matrix protein synthesis by cultured Normal human dermal fibroblasts. Sci Rep. (2018) 8:10474. doi: 10.1038/s41598-018-28492-w
6. “Collagen Supplements Market Size Report, 2022 - 2028.” (2022). Available online at: https://www.grandviewresearch.com/industry-analysis/collagen-supplement-market-report (Accessed February 20, 2025).
7. Pu, S-Y, Huang, Y-L, Pu, C-M, Kang, Y-N, Hoang, KD, Chen, K-H, et al. Effects of oral collagen for skin anti-aging: a systematic review and meta-analysis. Nutrients. (2023) 15:2080. doi: 10.3390/nu15092080
8. Kaspute, G, Ramanavicius, A, and Prentice, U. Molecular imprinting Technology for Advanced Delivery of essential oils. Polymers. (2024) 16:17. doi: 10.3390/polym16172441
9. Gwiazda, M, Bhardwaj, SK, Kijeńska-Gawrońska, E, Swieszkowski, W, Sivasankaran, U, and Kaushik, A. Impedimetric and plasmonic sensing of collagen I using a half-antibody-supported, au-modified, self-assembled monolayer system. Biosensors. (2021) 11:227. doi: 10.3390/bios11070227
10. Sakamoto, H, Watanabe, K, Koto, A, Koizumi, G, Satomura, T, Watanabe, S, et al. A bienzyme electrochemical biosensor for the detection of collagen L-hydroxyproline. Sens Bio-Sens Res. (2015) 4:37–9. doi: 10.1016/j.sbsr.2015.03.002
11. Wang, X, Yue, O, Liu, X, Hou, M, and Zheng, M. A novel bio-inspired multi-functional collagen aggregate based flexible sensor with multi-layer and internal 3D network structure. Chem Eng J. (2020) 392:123672. doi: 10.1016/j.cej.2019.123672
12. Afsarimanesh, N, Mukhopadhyay, SC, and Kruger, M. Molecularly imprinted polymer-based electrochemical biosensor for bone loss detection. IEEE Trans Biomed Eng. (2018) 65:1264–71. doi: 10.1109/TBME.2017.2744667
13. Cabaleiro-Lago, C, Hasterok, S, Gjörloff Wingren, A, and Tassidis, H. Recent advances in molecularly imprinted polymers and their disease-related applications. Polymers. (2023) 15:21. doi: 10.3390/polym15214199
14. McKleroy, W, Lee, T-H, and Atabai, K. Always cleave up your mess: targeting collagen degradation to treat tissue fibrosis. Am J Physiol Lung Cell Mol Physiol. (2013) 304:L709–21. doi: 10.1152/ajplung.00418.2012
15. Bonouvrie, DS, de Boer, H, and Aarts, EO. Three-year follow-up of bone status in male patients after bariatric surgery-a prospective single-Center cohort study. Surg Obes Relat Dis. (2021) 17:771–9. doi: 10.1016/j.soard.2020.11.019
16. Breasail, MÓ, Ward, KA, Schoenbuchner, SM, Ceesay, M, Mendy, M, Jarjou, LM, et al. Pregnancy-related change in pQCT and bone biochemistry in a population with a habitually low calcium intake. J Bone Miner Res. (2021) 36:1269–80. doi: 10.1002/jbmr.4295
17. Curtis, EM, Parsons, C, Maslin, K, D'Angelo, S, Moon, RJ, Crozier, SR, et al. Bone turnover in pregnancy, measured by urinary CTX, is influenced by vitamin D supplementation and is associated with maternal bone health: findings from the maternal vitamin D osteoporosis study (MAVIDOS) trial. Am J Clin Nutr. (2021) 114:1600–11. doi: 10.1093/ajcn/nqab264
18. Feehan, O, Armstrong, DJ, Magee, PJ, Pourshahidi, KL, Strain, JJ, Beggan, L, et al. Vitamin D and bone health of older adults within care homes: an observational study. Nutrients. (2022) 14:2680. doi: 10.3390/nu14132680
19. Morato-Martínez, M, López-Plaza, B, Santurino, C, Palma-Milla, S, and Gómez-Candela, C. A dairy product to reconstitute enriched with bioactive nutrients stops bone loss in high-risk menopausal women without pharmacological treatment. Nutrients. (2020) 12:2203. doi: 10.3390/nu12082203
20. Stojanović, E, Jakovljević, V, Scanlan, AT, Dalbo, VJ, and Radovanović, D. Vitamin D3 supplementation reduces serum markers of bone resorption and muscle damage in female basketball players with vitamin D inadequacy. Eur J Sport Sci. (2022) 22:1532–42. doi: 10.1080/17461391.2021.1953153
21. Cameli, N, Silvestri, M, Mariano, M, and Berardesca, E. Effects of food supplements and a topical solution containing Nanosilicon on skin hydration, barrier function, and elasticity. J Cosmet Dermatol. (2021) 20:32–5. doi: 10.1111/jocd.14099
22. Low, E, Alimohammadiha, G, Smith, LA, Costello, LF, Przyborski, SA, von Zglinicki, T, et al. How good is the evidence that cellular senescence causes skin ageing? Ageing Res Rev. (2021) 71:101456. doi: 10.1016/j.arr.2021.101456
23. Shin, J-W, Kwon, S-H, Choi, J-Y, Na, J-I, Huh, C-H, Choi, H-R, et al. Molecular mechanisms of dermal aging and antiaging approaches. Int J Mol Sci. (2019) 20:9. doi: 10.3390/ijms20092126
24. Fisher, GJ, Shao, Y, He, T, Qin, Z, Perry, D, Voorhees, JJ, et al. Reduction of fibroblast size/mechanical force Down-regulates TGF-β type II receptor: implications for human skin aging. Aging Cell. (2016) 15:67–76. doi: 10.1111/acel.12410
25. Fisher, GJ, Varani, J, and Voorhees, JJ. Looking older: fibroblast collapse and therapeutic implications. Arch Dermatol. (2008) 144:666–72. doi: 10.1001/archderm.144.5.666
26. Moretti, L, Stalfort, J, Harrison Barker, T, and Abebayehu, D. The interplay of fibroblasts, the extracellular matrix, and inflammation in scar formation. J Biol Chem. (2021) 298:101530. doi: 10.1016/j.jbc.2021.101530
27. Vanitchanont, M, Vallibhakara, SA-O, Sophonsritsuk, A, and Vallibhakara, O. Effects of multispecies probiotic supplementation on serum bone turnover markers in postmenopausal women with osteopenia: a randomized, double-blind, placebo-controlled trial. Nutrients. (2024) 16:461. doi: 10.3390/nu16030461
28. Chan, L-P, Tseng, Y-P, Liu, C, and Liang, C-H. Fermented pomegranate extracts protect against oxidative stress and aging of skin. J Cosmet Dermatol. (2022) 21:2236–45. doi: 10.1111/jocd.14379
29. Kozior, M, Olusoji Aboyeji Demehin, MMR, O’Connell, S, and Philip Michael Jakeman,. The temporal change in ionised calcium, parathyroid hormone and bone metabolism following ingestion of a plant- sourced marine mineral + protein isolate in healthy young adults. Nutrients. (2024) 16:3110. doi: 10.3390/nu16183110
30. Chen, L, Lv, Y, Xu, F, and Zhong, F. The effect of oral supplements containing collagen peptides rich in X-Hyp or X-Hyp-Gly compared with normal collagen hydrolysates on skin elasticity and collagen holes: a randomised double-blind clinical study. Food Funct. (2023) 14:10628–38. doi: 10.1039/D3FO02873A
31. Evans, M, Lewis, ED, Zakaria, N, Pelipyagina, T, and Guthrie, N. A randomized, triple-blind, placebo-controlled, parallel study to evaluate the efficacy of a freshwater marine collagen on skin wrinkles and elasticity. J Cosmet Dermatol. (2021) 20:825–34. doi: 10.1111/jocd.13676
32. Nomoto, T, and Iizaka, S. Effect of an Oral nutrition supplement containing collagen peptides on stratum corneum hydration and skin elasticity in hospitalized older adults: a Multicenter open-label randomized controlled study. Adv Skin Wound Care. (2020) 33:186. doi: 10.1097/01.ASW.0000655492.40898.55
33. Milani, M, and Colombo, FGFM-O-Trial Investigators Group: Chiara Baraldo (Padova), Mauro Barbareschi (Milano), Paolo Chieco (Ruvo di Puglia), Laura Colonna (Roma), Mandel Victor Desmond (Modena), Maria Cristina Fiorucci (Genova). Efficacy and tolerability of an oral supplement containing amino acids, iron, selenium, and marine hydrolyzed collagen in subjects with hair loss (androgenetic alopecia, AGA or FAGA or telogen effluvium). A prospective, randomized, 3-month, controlled, assessor-blinded study. Skin Res Technol. (2023) 29:e13381. doi: 10.1111/srt.13381
34. Vleminckx, S, Virgillo, N, Asserin, J, Prawitt, J, Silva, C, and F,. Influence of collagen peptide supplementation on visible signs of skin and nail health and -aging in an east Asian population: a double blind, randomized, placebo-controlled trial. J Cosmet Dermatol. (2024) 23:3645–53. doi: 10.1111/jocd.16458
35. Genc, AS, Tilmaz, AK, Anil, B, Salkilic, EK, Akdemir, E, Guzel, B, et al. The effect of supplementation with type I and type III collagen peptide and type II hydrolyzed collagen on pain, quality of life and physical function in patients with Meniscopathy: a randomized, double-blind, placebo- controlled study. BMC Musculoskelet Disord. (2025) 26:17. doi: 10.1186/s12891-024-08244-w
36. Pan, J, Cai, Y, Zhang, C, and Xu, S. Intra-articular delivery of geraniol encapsulated by pH/redox-responsive nanogel ameliorates osteoarthritis by regulating oxidative stress and inflammation. J Mol Histol. (2023) 54:579–91. doi: 10.1007/s10735-023-10163-4
37. Thomas, DT, Ashish John Prabhakar, CE, Patel, VD, Palaniswamy, V, Molly Cynthia Dsouza, SR, and Kamat, YD. Comparison of single and combined treatment with exercise therapy and collagen supplementation on early knee arthritis among athletes—a quasi-randomized trial. Int J Environ Res Public Health. (2023) 20:7088. doi: 10.3390/ijerph20237088
38. Kuwaba, K, Kusubata, M, Saito, M, and Mizuno, K. Dietary collagen peptides ameliorate the mood status of fatigue and Vigor: a randomized, double-blinded, placebo-controlled, parallel-group comparative trial. J Dietary Supplements. (2024) 21:791–807. doi: 10.1080/19390211.2024.2399343
39. Neltner, TJ, Sahoo, PK, Smith, RW, Anders, JPV, Arnett, JE, Schmidt, RJ, et al. Effects of 8 weeks of shilajit supplementation on serum pro-C1α1, a biomarker of type 1 collagen synthesis: a randomized control trial. J Diet Suppl. (2024) 21:1–12. doi: 10.1080/19390211.2022.2157522
40. Hilkens, L, van Schijndel, N, Weijer, VCR, Decroix, L, Bons, J, van Loon, LJC, et al. Jumping exercise combined with collagen supplementation preserves bone mineral density in elite cyclists. Int J Sport Nutr Exerc Metab. (2023) 38–47. doi: 10.1123/ijsnem.2023-0080
41. Kviatkovsky, SA, Hickner, RC, Cabre, HE, Small, SD, and Ormsbee, MJ. Collagen peptides supplementation improves function, pain, and physical and mental outcomes in active adults. J Int Soc Sports Nutr. (2023) 20:2243252. doi: 10.1080/15502783.2023.2243252
42. López-Yoldi, M, Riezu-Boj, JI, Abete, I, Ibero-Baraibar, I, Aranaz, P, González-Salazar, I, et al. Anti-obesity effects of a collagen with low digestibility and high swelling capacity: a human randomized control trial. Nutrients. (2024) 16:3550. doi: 10.3390/nu16203550
43. Jerger, S, Centner, C, Lauber, B, Seynnes, O, Sohnius, T, Jendricke, P, et al. Effects of specific collagen peptide supplementation combined with resistance training on Achilles tendon properties. Scand J Med Sci Sports. (2022) 32:1131–41. doi: 10.1111/sms.14164
44. Nulty, CD, Tang, JCY, Dutton, J, Dunn, R, Fraser, WD, Enright, K, et al. Hydrolyzed collagen supplementation prior to resistance exercise augments collagen synthesis in a dose-response manner in resistance-trained, middle-aged men. Am J Physiol Endocrinol Metab. (2024) 327:E668–77. doi: 10.1152/ajpendo.00252.2024
45. Žmitek, K, Žmitek, J, Butina, MR, and Pogačnik, T. Effects of a combination of water-soluble coenzyme Q10 and collagen on skin parameters and condition: results of a randomised, placebo-controlled, double-blind study. Nutrients. (2020) 12:618. doi: 10.3390/nu12030618
46. Revert-Ros, F, Ventura, I, Prieto-Ruiz, JA, Hernández- Andreu, JM, and Revert, F. The versatility of collagen in pharmacology: targeting collagen, targeting with collagen. Int J Mol Sci. (2024) 25:6523. doi: 10.3390/ijms25126523
47. Lee, M, Kim, E, Ahn, H, Son, S, and Lee, H. Oral intake of collagen peptide NS improves hydration, elasticity, desquamation, and wrinkling in human skin: a randomized, double-blinded, placebo-controlled study. Food Funct. (2023) 14:3196–207. doi: 10.1039/d2fo02958h
48. van Dam, L, Trenik, R, Mensink, M, de Vos, RJ, and Zwerver, J. The JUMPFOOD study: additional effect of hydrolyzed collagen and vitamin C to exercise treatment for patellar tendinopathy (jumper’s knee) in athletes—study protocol for a double-blind randomized controlled trial. Trials. (2023) 24:768. doi: 10.1186/s13063-023-07783-2
49. Maia Campos, PMBG, Franco, RSB, Kakuda, L, Cadioli, GF, Costa, GMD’A, and Bouvret, E. Oral supplementation with hydrolyzed fish cartilage improves the morphological and structural characteristics of the skin: a double-blind, placebo-controlled clinical study. Molecules. (2021) 26:4880. doi: 10.3390/molecules26164880
50. Kotowicz, Z, Pich-Czekierda, A, Proszowska, P, Orzeł, A, Sieniawska, D, Madoń, M, et al. Advantages of oral collagen supplementation. Review of the literature. J Educ Health Sport. (2024) 70:50183. doi: 10.12775/JEHS.2024.70.50183
51. Almagro, M. Cristinade 2020 The use of collagen hydrolysates and native collagen in osteoarthritis Am J Biomed Sci Res 7:530 doi: 10.34297/AJBSR.2020.07.001217
52. Ayhan, FF, Demirci Çoban, A, Utkan Karasu, A, Karaoğlan, B, Çınar, E, Eyigör, S, et al. The effect of combined hydrolyzed type 2 collagen, methylsulfonylmethane, glucosamine sulfate and chondroitin sulfate supplementation on knee osteoarthritis symptoms. Turk J Phys Med Rehabil. (2024) 70:259–68. doi: 10.5606/tftrd.2024.13735
53. Jendricke, P, Centner, C, Zdzieblik, D, Gollhofer, A, and Konig, D. Specific collagen peptides in combination with resistance training improve body composition and regional muscle strength in premenopausal women: a randomized controlled trial. Nutrients. (2019) 11:892. doi: 10.3390/nu11040892
54. Osawa, Y, Murata, K, Usui, M, Kuba, Y, Le, HT, Mikami, N, et al. EXOC1 plays an integral role in spermatogonia pseudopod elongation and spermatocyte stable 10: syncytium formation in mice. eLife. (2021):e59759. doi: 10.7554/eLife.59759
55. Buda, M, Dlimi, S, Parisi, M, Benoni, A, Bisinella, G, and Di Fabio, S. Subacromial injection of hydrolyzed collagen in the symptomatic treatment of rotator cuff tendinopathy: an observational multicentric prospective study on 71 patients. JSES International. (2023) 7:799–804. doi: 10.1016/j.jseint.2023.06.009
56. Wang, X, Wei, W, Krzeszinski, JY, Wang, Y, and Wan, Y. A liver-bone endocrine relay by IGFBP1 promotes Osteoclastogenesis and mediates FGF21-induced bone resorption. Cell Metab. (2015) 22:811–24. doi: 10.1016/j.cmet.2015.09.010
57. Inacio, PAQ, Gomes, YSM, de Aguiar, AJN, Lopes-Martins, PSL, Aimbire, F, Leonardo, PS, et al. The effects of collagen peptides as a dietary supplement on muscle damage recovery and fatigue responses: an integrative review. Nutrients. (2024) 16:3403. doi: 10.3390/nu16193403
58. Alhalabi, R, Nasrallah, B, Rahman, R, Muad, H, and Qureshi, A. Chronic recurrent multifocal osteomyelitis mimicking scurvy in a child: a case report. Cureus. (2023) 15:2243252. doi: 10.7759/cureus.38880
59. Hebail, F. Determination of vitamin C concentration in various fresh orange and lemon samples from Janzour region using volumetric titration. AlQalam J Med App Sci. (2024) 7:1214–1218. doi: 10.54361/ajmas.247444
60. Asserin, J, Lati, E, Shioya, T, and Prawitt, J. The effect of Oral collagen peptide supplementation on skin moisture and the dermal collagen network: evidence from an ex vivo model and randomized, placebo-controlled clinical trials. J Cosmet Dermatol. (2015) 14:291–301. doi: 10.1111/jocd.12174
61. Amini, N, Osterlund, C, Curpen, J, Lafon-Kolb, V, Richard, T, and Visdal-Johnsen, L. Phytoestrogens as natural anti-aging solutions for enhanced collagen synthesis in skin. J Cosmet Dermatol. (2025) 24:e16719. doi: 10.1111/jocd.16719
62. Deters, AM, Schröder, KR, and Hensel, A. Kiwi fruit (Actinidia chinensis L.) polysaccharides exert stimulating effects on cell proliferation via enhanced growth factor receptors, energy production, and collagen synthesis of human keratinocytes, fibroblasts, and skin equivalents. J Cell Physiol. (2005) 202:717–22. doi: 10.1002/jcp.20161
63. Jang, CY. A quantitative analysis of the active ingredients of broad-leaved bamboo and study on its skin condition improvement effect. Int J High School Res. (2023) 5:12–7. doi: 10.36838/v5i1.3
64. Bonatto, M d S, Feltran, G d S, Barbosa, TP, Pereira, DA, Santos, SS, Mendes, PGJ, et al. Green tea and hyaluronic acid gel enhance fibroblast activation and improves the gingival healing post-third molar extraction. Sci Rep. (2024) 14:7124. doi: 10.1038/s41598-024-57821-5
65. Fletcher, NM, Awonuga, AO, Saed, MG, Abu-Soud, HM, Diamond, MP, and Saed, GM. Lycopene, a powerful antioxidant, significantly reduces the development of the adhesion phenotype. Syst Biol Reprod Med. (2014) 60:14–20. doi: 10.3109/19396368.2013.847129
66. Baranwal, J, Barse, B, Gatto, G, Broncova, G, and Kumar, A. Electrochemical sensors and their applications: a review. Chem. (2022) 10:363. doi: 10.3390/chemosensors10090363
67. Hasseb, AA, Abdel Ghani, N d T, Shehab, OR, and El Nashar, RM. Application of molecularly imprinted polymers for electrochemical detection of some important biomedical markers and pathogens. Curr Opin Electrochem. (2022) 31:100848. doi: 10.1016/j.coelec.2021.100848
68. Napit, R, Jaysawal, SK, Chowdhury, R, Catague, J, Melke, H, Pham, CV, et al. Aptasensors and advancement in molecular recognition technology. Adv Mater Technol. (2025) 10:2400504. doi: 10.1002/admt.202400504
69. Das, A, and Theato, P. Activated Ester containing polymers: opportunities and challenges for the Design of Functional Macromolecules. Chem Rev. (2016) 116:1434–95. doi: 10.1021/acs.chemrev.5b00291
70. Aydin, EB, Aydin, M, and Sexginturk, MK. Advances in electrochemical immunosensors In: G. S. Makowski editor. Advances in clinical chemistry, vol. 92. Amsterdam, Netherlands: Elsevier (2019)
71. Ertuğrul Uygun, HD, and Demir, MN. A novel molecularly imprinted polymers on self-assembly monolayer gold electrode impedimetric detection of dopamine. J Mater Sci Mater Electron. (2025) 36:441. doi: 10.1007/s10854-025-14375-0
72. Ely, F, Salvador, M, Minary-Jolandan, M, Ibrahim, H, Malheiros-Silveira, GN, Nome, RA, et al. Nanoimprinted collagen plasmonic sensors. Small Struct. (2025):e202500469. doi: 10.1002/sstr.202500469
73. Mao, P, Li, H, and Yu, Z. A review of skin-wearable sensors for non-invasive health monitoring applications. Sensors. (2023) 23:3673. doi: 10.3390/s23073673
74. Kaspute, G, Ramanavicius, A, and Prentice, U. Natural drug delivery Systems for the Treatment of neurodegenerative diseases. Mol Biol Rep. (2025) 52:217. doi: 10.1007/s11033-025-10286-9
75. Xu, Q, Torres, JE, Hakim, M, Babiak, PM, Pal, P, Battistoni, CM, et al. Collagen- and hyaluronic acid-based hydrogels and their biomedical applications. Mater Sci Eng R Rep. (2021) 146:100641. doi: 10.1016/j.mser.2021.100641
76. Fort, I, Cotet, C, Pop, C, Baia, M, and Baia, L. Advanced graphene-based materials for electrochemical biomarkers and protein detection In: E. W. Wambu editor. Chemistry of graphene - synthesis, reactivity, applications and toxicities. London, UK: IntechOpen (2024)
77. Yulianti, ES, Rahman, SF, and Whulanza, Y. Molecularly imprinted polymer-based sensor for electrochemical detection of cortisol. Biosensors. (2022) 12:1090. doi: 10.3390/bios12121090
78. Wang, Q, Ren, Z-H, Zhao, W-M, Wang, L, Yan, X, Zhu, AS, et al. Research advances on surface plasmon resonance biosensors. Nanoscale. (2022) 14:564–91. doi: 10.1039/D1NR05400G
79. Hwang, J, Huang, Y, Burwell, TJ, Peterson, NC, Connor, J, Weiss, SJ, et al. In situ imaging of tissue Remodeling with collagen hybridizing peptides. ACS Nano. (2017) 11:9825–35. doi: 10.1021/acsnano.7b03150
80. Naranda, J, Bračič, M, Vogrin, M, Maver, U, and Trojner, T. Practical use of quartz crystal microbalance monitoring in cartilage tissue engineering. J Functional Biomaterials. (2022) 13:159. doi: 10.3390/jfb13040159
81. Shokrani, A, Shokrani, H, Munir, MT, Kucinska-Lipka, J, Khodadadi Yazdi, M, and Saeb, MR. Monitoring osteoarthritis: a simple mathematical model. Biomed Eng Adv. (2022) 4:100050. doi: 10.1016/j.bea.2022.100050
82. Cheah, E, Bansal, M, Nguyen, L, Chalard, A, Malmström, J, O'Carroll, SJ, et al. Electrically responsive release of proteins from conducting polymer hydrogels. Acta Biomater. (2023) 158:87–100. doi: 10.1016/j.actbio.2023.01.013
83. Borah, R, Diez Clarke, D, Upadhyay, J, and Monaghan, MG. From innovation to clinic: emerging strategies harnessing electrically conductive polymers to enhance electrically stimulated peripheral nerve repair. Mater Today Bio. (2025) 30:101415. doi: 10.1016/j.mtbio.2024.101415
84. Pham, TT, Hong, EM, Moy, WJ, Zhao, J, Hu, AC, Barnes, CH, et al. The biophysical effects of localized electrochemical therapy on porcine skin. J Dermatol Sci. (2020) 97:179–86. doi: 10.1016/j.jdermsci.2020.01.006
85. Tyagi, V, Serna-Jiménez, CE, and Kalia, YN. Controlled simultaneous iontophoresis of Buflomedil hydrochloride and dexamethasone sodium phosphate to the mucosa for Oral submucous fibrosis. Int J Pharm. (2021) 607:121009. doi: 10.1016/j.ijpharm.2021.121009
86. Rani, A, Sindhu, A, Yao, T-J, Horng, J-C, and Venkatesu, P. Profiling the impact of choline chloride on the self-assembly of collagen mimetic peptide (pro-Hyp-Gly)10. Process Biochem. (2022) 121:26–34. doi: 10.1016/j.procbio.2022.06.024
87. Qin, C, Yue, Z, Chao, Y, Forster, RJ, Maolmhuaidh, FÓ, Huang, X-F, et al. Bipolar electroactive conducting polymers for wireless cell stimulation. Appl Mater Today. (2020) 21:100804. doi: 10.1016/j.apmt.2020.100804
88. Sun, X, Xu, X, Xue, R, Zhang, L, and Liu, L. Surface modification of zirconium alloy implants by collagen encapsulated strontium ranelate@PCN-224 coating to improve biocompatibility and promote osseointegration. Mater Chem Phys. (2023) 293:126910. doi: 10.1016/j.matchemphys.2022.126910
89. Andonegi, M, Correia, DM, Costa, CM, Lanceros-Mendez, S, de la Caba, K, and Guerrero, P. Tailoring physicochemical properties of collagen-based composites with ionic liquids and wool for advanced applications. Polymer. (2022) 252:124943. doi: 10.1016/j.polymer.2022.124943
90. El-Husseiny, HM, Mady, EA, Hamabe, L, Abugomaa, A, Shimada, K, Yoshida, T, et al. Smart/stimuli-responsive hydrogels: cutting-edge platforms for tissue engineering and other biomedical applications. Materials Today Bio. (2022) 13:100186. doi: 10.1016/j.mtbio.2021.100186
91. Sánchez-Cid, P, Jiménez-Rosado, M, Rubio-Valle, JF, Romero, A, Ostos, FJ, Rafii-el-Idrissi Benhnia, M, et al. Biocompatible and thermoresistant hydrogels based on collagen and chitosan. Polymers. (2022) 14:272. doi: 10.3390/polym14020272
92. Ribeiro, M, Simões, M, Vitorino, C, and Mascarenhas-Melo, F. Hydrogels in cutaneous wound healing: insights into characterization, properties, formulation and therapeutic potential. Gels. (2024) 10:188. doi: 10.3390/gels10030188
93. Zhang, L, Zhou, Y, Su, D, Wu, S, Zhou, J, and Chen, J. Injectable, self-healing and pH responsive stem cell factor loaded collagen hydrogel as a dynamic bioadhesive dressing for diabetic wound repair. J Mater Chem B. (2021) 9:5887–97. doi: 10.1039/D1TB01163D
94. Ren, X, Tu, V, Bischoff, D, Weisgerber, DW, Lewis, MS, Yamaguchi, DT, et al. Nanoparticulate mineralized collagen scaffolds induce in vivo bone regeneration independent of progenitor cell loading or exogenous growth factor stimulation. Biomaterials. (2016) 89:67–78. doi: 10.1016/j.biomaterials.2016.02.020
95. Liberto, Pamela. "CoMatryx collagen wound dressing 1 gram pouch." 2017. FDA. Accessed November 7, 2025. Available online at: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm?ID=K171645&utm_source=chatgpt.com.
96. Schulze, C, Schunck, M, Zdzieblik, D, and Oesser, S. Impact of specific bioactive collagen peptides on joint discomforts in the lower extremity during daily activities: a randomized controlled trial. Int J Environ Res Public Health. (2024) 21:6. doi: 10.3390/ijerph21060687
97. Bongers, CSWG, Ten Haaf, DSM, Catoire, M, Kersten, B, Wouters, JA, Eijsvogels, TMH, et al. Effectiveness of collagen supplementation on pain scores in healthy individuals with self-reported knee pain: a randomized controlled trial. Appl Physiol Nutr Metab. (2020) 45:793–800. doi: 10.1139/apnm-2019-0654
98. Mohammed, A, and He, S. A double-blind, randomized, placebo- controlled trial to evaluate the efficacy of a hydrolyzed chicken collagen type II supplement in alleviating joint discomfort. Nutrients. (2021) 13:2454. doi: 10.3390/nu13072454
99. Devasia, S, Joseph, JT, P S, S, Koizumi, S, Clarke, L, V T, S, et al. Management and amelioration of knee joint osteoarthritis in adults using a novel high-functional bovine collagen peptide as a nutritional therapy: a double-blind, prospective, multicentric, randomized, active and placebo controlled, five-arm, clinical study to evaluate the efficacy, safety, and tolerability. Cartilage. (2024) 15:363–74. doi: 10.1177/19476035231221211
100. Kuwaba, K, Kusubata, M, Taga, Y, Igarashi, H, Nakazato, K, and Mizuno, K. Dietary collagen peptides alleviate exercise-induced muscle soreness in healthy middle-aged males: a randomized double-blinded crossover clinical trial. J Int Soc Sports Nutr. (2023) 20:2206392. doi: 10.1080/15502783.2023.2206392
101. Zdzieblik, D, Jendricke, P, Oesser, S, Gollhofer, A, and König, D. The influence of specific bioactive collagen peptides on body composition and muscle strength in middle-aged, untrained men: a randomized controlled trial. Int J Environ Res Public Health. (2021) 18:4837. doi: 10.3390/ijerph18094837
102. Barclay, R, Coad, J, Schraders, K, and Barnes, MJ. Comparing the effects of collagen hydrolysate and dairy protein on recovery from eccentric exercise: a double blind, placebo-controlled study. Nutrients. (2024) 16:4389. doi: 10.3390/nu16244389
103. Schön, C, Knaub, K, Alt, W, Durkee, S, Saiyed, Z, and Juturu, V. UC-II undenatured type II collagen for knee joint flexibility: a Multicenter, randomized, double-blind, placebo-controlled clinical study. J Integr Complement Med. (2022) 28:540–8. doi: 10.1089/jicm.2021.0365
104. Jerger, S, Centner, C, Lauber, B, Seynnes, O, Friedrich, T, Lolli, D, et al. Specific collagen peptides increase adaptions of patellar tendon morphology following 14-weeks of high-load resistance training: a randomized-controlled trial. Eur J Sport Sci. (2023) 23:2329. doi: 10.1080/17461391.2023.2232758
105. Žmitek, K, Žmitek, J, Hristov, H, Rogl Butina, M, Keršmanc, P, and Pogačnik, T. The effects of dietary supplementation with collagen and vitamin C and their combination with hyaluronic acid on skin density, texture and other parameters: a randomised, double-blind, placebo-controlled trial. Nutrients. (2024) 16:1908. doi: 10.3390/nu16121908
106. Thomas, C, Kingshott, RN, Allott, KM, Tang, JCY, Dunn, R, Fraser, WD, et al. Collagen peptide supplementation before bedtime reduces sleep fragmentation and improves cognitive function in physically active males with sleep complaints. Eur J Nutr. (2024) 63:323–35. doi: 10.1007/s00394-023-03267-w
Keywords: collagen, supplement, clinical trial, biological effect, biosensors, drug delivery systems
Citation: Ivaskiene T, Viskelis J, Streimikyte P, Savickaitė M, Mobasheri A and Kaspute G (2025) Collagen supplementation and regenerative health: advances in biomarker detection and smart material integration. Front. Nutr. 12:1716166. doi: 10.3389/fnut.2025.1716166
Edited by:
Guanwu Li, Shanghai University of Traditional Chinese Medicine, ChinaReviewed by:
Bethuel Daurai, North Eastern Hill University, IndiaMurat Çelik, Ankara University, Türkiye
Carlos Mastrangelo, University of Utah, United States
Copyright © 2025 Ivaskiene, Viskelis, Streimikyte, Savickaitė, Mobasheri and Kaspute. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Tatjana Ivaskiene, dGF0amFuYS5pdmFza2llbmVAaW1jZW50cmFzLmx0
†ORCID: Tatjana Ivaskiene, orcid.org/0000-0003-2064-6792
Jonas Viskelis, orcid.org/0000-0002-1074-8384
Paulina Streimikyte, orcid.org/0000-0001-8975-501X
Ali Mobasheri, orcid.org/0000-0001-6261-1286
Greta Kaspute, orcid.org/0009-0002-0605-3317